MCF Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-489
| Closed | -$121K | – | 715 |
|
|
2026
Q2 | $121K | Buy |
489
+369
| +308% | +$79.5K | ﹤0.01% | 505 |
|
|
2026
Q1 | $24.1K | Hold |
120
| – | – | ﹤0.01% | 772 |
|
|
2025
Q4 | $24.8K | Hold |
120
| – | – | ﹤0.01% | 648 |
|
|
2025
Q3 | $21.5K | Hold |
120
| – | – | ﹤0.01% | 575 |
|
|
2025
Q2 | $19.4K | Hold |
120
| – | – | ﹤0.01% | 557 |
|
|
2025
Q1 | $20.4K | Hold |
120
| – | – | ﹤0.01% | 543 |
|
|
2024
Q4 | $19.9K | Hold |
120
| – | – | ﹤0.01% | 557 |
|
|
2024
Q3 | $20.6K | Hold |
120
| – | – | ﹤0.01% | 546 |
|
|
2024
Q2 | $18.5K | Hold |
120
| – | – | ﹤0.01% | 555 |
|
|
2024
Q1 | $18.5K | Hold |
120
| – | – | ﹤0.01% | 545 |
|
|
2023
Q4 | $19K | Hold |
120
| – | – | ﹤0.01% | 509 |
|
|
2023
Q3 | $17.6K | Hold |
120
| – | – | ﹤0.01% | 503 |
|
|
2023
Q2 | $18.4K | Hold |
120
| – | – | ﹤0.01% | 484 |
|
|
2023
Q1 | $18.6K | Hold |
120
| – | – | ﹤0.01% | 480 |
|
|
2022
Q4 | $18.5K | Hold |
120
| – | – | ﹤0.01% | 461 |
|
|
2022
Q3 | $16K | Hold |
120
| – | – | ﹤0.01% | 494 |
|
|
2022
Q2 | $16K | Hold |
120
| – | – | ﹤0.01% | 466 |
|
|
2022
Q1 | $18K | Buy |
+120
| New | +$17.8K | ﹤0.01% | 467 |
|
|
2021
Q4 | – | Sell |
-120
| Closed | -$20K | – | 256 |
|
|
2021
Q3 | $20K | Hold |
120
| – | – | ﹤0.01% | 414 |
|
|
2021
Q2 | $21K | Hold |
120
| – | – | ﹤0.01% | 382 |
|
|
2021
Q1 | $19K | Hold |
120
| – | – | ﹤0.01% | 370 |
|
|
2020
Q4 | $20K | Hold |
120
| – | – | ﹤0.01% | 336 |
|
|
2020
Q3 | $19K | Hold |
120
| – | – | ﹤0.01% | 325 |
|
|
2020
Q2 | $20K | Hold |
120
| – | – | ﹤0.01% | 306 |
|
|
2020
Q1 | $16K | Hold |
120
| – | – | ﹤0.01% | 325 |
|
|
2019
Q4 | $18K | Hold |
120
| – | – | ﹤0.01% | 337 |
|
|
2019
Q3 | $15K | Hold |
120
| – | – | ﹤0.01% | 341 |
|
|
2019
Q2 | $17K | Hold |
120
| – | – | ﹤0.01% | 328 |
|
|
2019
Q1 | $18K | Hold |
120
| – | – | ﹤0.01% | 311 |
|
|
2018
Q4 | $15K | Hold |
120
| – | – | ﹤0.01% | 318 |
|
|
2018
Q3 | $19K | Buy |
+120
| New | +$18.2K | ﹤0.01% | 302 |
|
|
2018
Q2 | – | Sell |
-120
| Closed | -$16K | – | 451 |
|
|
2018
Q1 | $16K | Hold |
120
| – | – | ﹤0.01% | 304 |
|
|
2017
Q4 | $15K | Hold |
120
| – | – | ﹤0.01% | 312 |
|
|
2017
Q3 | $15K | Hold |
120
| – | – | ﹤0.01% | 318 |
|
|
2017
Q2 | $14K | Hold |
120
| – | – | ﹤0.01% | 341 |
|
|
2017
Q1 | $13K | Hold |
120
| – | – | ﹤0.01% | 336 |
|
|
2016
Q4 | $11K | Hold |
120
| – | – | ﹤0.01% | 305 |
|
|
2016
Q3 | $12K | Hold |
120
| – | – | ﹤0.01% | 306 |
|
|
2016
Q2 | $11K | Hold |
120
| – | – | ﹤0.01% | 334 |
|
|
2016
Q1 | $11K | Hold |
120
| – | – | ﹤0.01% | 310 |
|
|
2015
Q4 | $14K | Buy |
+120
| New | +$12.9K | ﹤0.01% | 297 |
|
Other funds holding FBT
MCF Advisors's FBT Position: Q3 2026 in Review
MCF Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 489 shares — an estimated $121K sold.
MCF Advisors first reported a position in FBT in Q4 2015 and held it in 41 quarters. The position peaked at $121K in Q2 2026. 164 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- MCF Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
- MCF Advisors sold 489 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $121K.
- MCF Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and held it in 41 quarters.
- MCF Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $121K in Q2 2026.
- 164 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on MCF Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.